Greatland Gold Plc, Omega Diagnostics Group PLC and Mosman Oil and Gas Ltd

Greatland Gold Plc

Greatland Gold Plc (GGP) is a mining and exploration company with primary interests in gold. It operates 6 mining prospects in Australia where copper and cobalt are also prospected along with gold. The company’s prospects are Paterson in north Western Australia, Firetower project in Northern Tasmania, Panorama project in the Pilbara region of Western Australia, Ernest Giles in Yilgarn, Central Western Australia, Warrentinna in north-eastern Tasmania and Bromos in the southern Yilgarn region of Western Australia.

The company is headquartered in London with its shares listed on the AIM at the London Stock Exchange where they trade with the ticker name GGP.

Recent News Update

The company on 20 August 2019 came out with a report of the further exploration efforts in its Panorama prospect. The report stated that the drill established the existance of higher-grade copper-gold mineralisation at the site.

Financial Update of Greatland Gold Plc for H1 FY19 ended 31 December 2018

Source – Company half-yearly report publication for FY 2019

The company is an exploration stage company without any sales and is still funding its mining and exploration efforts. The finance revenue for the Half-year ended 31 December 2018 was £2587, whereas it was a finance revenue of £1108 for the period ended 31 December 2017. The operating loss for the Half-year ended 31 December 2018 was £1.46 million, compared to an operating loss of £718,096 for the period ended 31 December 2017. The net loss for the Half-year ended 31 December 2018 was £1.458 million, whereas it was a net loss of £716,988 for the Half-year ended 31 December 2017. The higher loss for the period was on account of higher exploration expenditure. The loss per share (diluted) of 0.05 pence was for the H1 ended 31 December 2018, whereas for the period ended 31 December 2017 it was a loss of 0.03 pence per share. The company has not declared any dividend for the Half-year ended 31 December 2018.

The share price performance of Greatland Gold Plc at the London Stock Exchange.

Daily Chart as on 21 August 2019, before the market close (Source: Thomson Reuters)

On 21 August 2019, at the time of writing of the report (before the market close, GMT 03.07 PM), GGP shares were trading on the London Stock Exchange at GBX 1.768, down by 1.23 per cent over the previous day's closing price of GBX 1.79. The stock has a 52- week High of GBX 2.55, and a 52-week low of GBX 0.975. The total market capitalisation of the company was £60.49 million.

Outlook

The company has a significant amount of confirmed deposits in its kitty. The value creation potential of all its assets is manifold, while the company’s rich ore finds will also significantly reduce its operating costs.

Omega Diagnostics Group PLC

Omega Diagnostics Group Plc (ODX) is the United Kingdom based medical diagnostics company; its products are targeted towards allergies and autoimmune type ailments. Its products include PATHOZYME® Ferritin, PATHOZYME® Luteinizing hormone, PATHOZYME® Prolactin and PATHOZYME® Oestradiol.

The company is headquartered in Alva, Scotland and its shares are listed on the London Stock Exchange where they trade under the ticker name ODX.

Recent News Update

The company on 20 August 2019 came out with an update that it has received an order of 20,000 units of its VISITECT® CD4 advanced disease test valued at about £80,000. The order has been placed by its Zimbabwean partners for use in that country, which has previously also placed an order of 50,000 units of the product. The test helps determine the status of HIV patients.

Financial Update of Omega Diagnostics Group PLC for H1 FY19 ending September 2018

Source – Company half - Year report publication for H1 FY19

The company for the half-year ended 30 September 2018 reported revenue of £5.227 million compared to revenue of £7.113 million for half-year ended 30 September 2017. The Gross profit for the half-year ended 30 September 2018 was £3.145 million, whereas it was a profit of £4.490 million for the period ended 30 September 2017. The operating profit after exceptional items for the half-year ended 30 September 2018 was £849,466, compared to an operating profit of £99,262 for the period ended 30 September 2017. The higher profits for the half-year were on account of lower administrative and selling and marketing costs. The earnings per share (diluted) of 0.6 pence was for the H1 ended 30 September 2018, whereas for the period ended 30 September 2017 it was 0.1 pence per share. The Company has not declared any dividend for the half-year ended 30 September 2018.  Â

 The share price performance of Omega Diagnostics Group PLC at the London Stock Exchange

Daily Chart as on 21 August 2019, before the market close (Source: Thomson Reuters)

On 21 August 2019, at the time of writing of the report (before the market close, GMT 03.50 PM), ODX shares were trading on the London Stock Exchange at GBX 9.625, up by 0.78 per cent over the previous day's closing price of GBX 9.55. The stock has a 52- week High of GBX 18.00, and a 52-week low of GBX 8.19. The total market capitalization of the company was around £12.73 million.

Outlook

The company’s products have found gainful usage in third world countries. They are helping countries with vulnerable population tackle major health risks. The order from Zimbabwe is only the beginning and it is expected that there will be more from the surrounding countries, thereby extending the company an opportunity to create lasting value for its shareholders.

Mosman Oil and Gas Ltd

Mosman Oil and Gas Ltd (MSMN) is an Australian oil and gas exploration company with exploration interests in United states and Australia. The company is mostly interested in Shale gas and has five projects in the United States namely, Arkoma Stacked Pay Project (Oklahoma), Welch Permian Basin (West Texas), Stanley (East Texas), Champion (East Texas) and Strawn Oil project (Texas). In Australia its project is called Amadeus project located in northern Australia

The company has its shares listed on AIM at the London stock exchange, where they trade under the ticker name MSMN.

Recent News update

The company has come out with a news update on 14 August 2019, that it has completed drilling in its Stanley -1 project in Texas and has found its target at 5,100 feet. Other than that, on 5 August 2019 the company informed via a release that it is about to spud the Stanley -3 well, as part of its strategic alliance with Baja Oil and Gas Company.

Financial Update of Mosman Oil and Gas Ltd for H1 FY19 ended December 2018

Source – Company half-year report publication for FY 2019

The company for the half-year ended 31 December 2018 reported revenue of $521,326 compared to revenue of $321,348 for the half year ended 31 December 2017. The Gross profit for the half year ended 31 December 2018 was $38,477, whereas it was a gross profit of $156,522 for the half-year period ended 31 December 2017. The loss before tax for the half year ended 31 December 2018 was $730,767, compared to a loss before tax of $731,046 for the half-year period ended 31 December 2017. The net loss for the half-year ended 31 December 2018 was $730,767, whereas it was a net loss of $731,046 for the half-year ended 31 December 2017. The lower profits for the half-year were on account of higher administrative and corporate expenses. The loss per share (diluted) of 0.14 cents was for the H1 ended 31 December 2018, whereas for the half-year period ended 31 December 2017 it was loss of 0.36 cents per share. The company has not declared any dividend for the half-year ended 31 December 2018.

The share price performance of Mosman Oil and Gas Ltd at the London Stock Exchange

Daily Chart as on 21 August 2019, before the market close (Source: Thomson Reuters)

On 21 August 2019, at the time of writing of the report (before the market close, GMT 03.10 PM), MSMN shares were trading on the London Stock Exchange at GBX 0.259, down by 4.07 per cent over the previous day's closing price of GBX 0.270. The stock has a 52- week High of GBX 0.74, and a 52-week low of GBX 0.21. The total market capitalisation of the company was £2.30 million.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK